Grace Therapeutics Income Statement (2011-2013) | GRCE

Income Statement May2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013
Revenue & cost
Revenue 385.000.00M-0.00M0.01M0.24M0.42M0.05M0.01M0.27M0.03M
Gross Profit 0.01M0.11M0.18M0.01M0.00M0.11M
Operating items
Selling, General & Administrative -0.64M-0.85M-1.17M-1.07M-1.09M-1.04M-1.09M-1.20M-1.85M
Operating Expenses -0.64M-0.85M-1.17M-1.07M-1.09M-1.04M-1.09M-1.20M-1.85M
Operating Income -1.02M-2.21M-1.55M-1.62M-1.74M-1.63M-1.99M-1.98M-3.26M
EBIT -1.02M-2.21M-1.55M-1.62M-1.74M-1.63M-1.99M-1.98M-3.26M
Non-operating items
Interest & Investment Income 0.01M0.01M-0.07M0.01M0.02M-0.01M-0.04M-0.01M-0.01M-0.01M
Other Non Operating Income -0.01M-0.01M0.00M0.02M0.01M-0.00M-0.03M0.00M-0.02M-0.00M
Non Operating Income -0.00M-0.01M-0.02M0.04M-0.01M-0.02M-0.13M-0.01M0.02M
Net income details
EBT -1.01M-2.20M-1.63M-1.61M-1.73M-1.64M-2.03M-1.99M-3.27M
Profit After Tax -1.02M2.21M-1.55M1.58M-1.75M1.61M-1.95M-1.97M3.24M-3.86M
Income from Continuing Operations -1.01M-2.20M-1.63M-1.61M-1.73M-1.64M-2.03M-1.99M-3.27M
Consolidated Net Income -1.01M-2.20M-1.63M-1.61M-1.73M-1.64M-2.03M-1.99M-3.27M
Income towards Parent Company -1.01M-2.20M-1.63M-1.61M-1.73M-1.64M-2.03M-1.99M-3.27M
Net Income towards Common Stockholders -1.01M-2.20M-1.63M-1.61M-1.73M-1.64M-2.03M-1.99M-3.27M
Additional items
EPS (Basic) -0.05M-0.03M-0.02M-0.08M-0.03M-0.02M-0.02M-0.07M-0.05M
Shares Outstanding (Weighted Average) 20.0080.00100.0020.0050.0070.0090.0030.0070.00120.00
EBITDA -0.69M-1.68M-0.86M-0.92M-1.04M-1.05M-1.37M-1.27M-1.76M-1.57M
Interest Expenses -385.00-0.00M0.00M-869.00-419.000.00M0.00M0.00M0.00M0.55M
Shares Outstanding 72.64M